title: GATA2_P4_ChIPSeq

status: Public on Jan 01 2014

data_processing:
7_GATA2_P4_s_1_aligned.xls; genome build: mm9
DNA libraries were sent to Illumina Sequencing Services for sequencing on a Genome Analyzer II. Sequences (35 bases) were aligned to the mouse genome (NCBI Build 37, July 2007) using Eland software. Aligns were extended in silico at their 39-ends to a length of 110-200 bp and assigned to 32-nt bins along the genome. The resulting histograms were stored in BAR (Binary Analysis Results) files. Peak locations were determined by applying a threshold of 18 (5 consecutive bins containing .18 aligns) and storing the resulting intervals in BED files (Affymetrix TAS software). These files were analyzed using Genpathway proprietary software that provides comprehensive information on genomic annotation, peak metrics and sample comparisons for all peaks (intervals).
Peaks: Peak detection was performed with the Model-based Analysis of ChIP-Seq (MACS) algorithm (http://liulab.dfci.harvard.edu/MACS/)

source_name: Mouse uterus

growth_protocol: 8 week old ovariectomized mice

extract_protocol: Lysates were clarified from sonicated nuclei and histone-DNA complexes were isolated with antibody.  ChIP and input DNA were amplified using the Illumina ChIP-Seq DNA Sample Prep Kit. Briefly, DNA ends were polished and 59-phosphorylated using T4 DNA polymerase, Klenow polymerase and T4 polynucleotide kinase. Addition of 3’ adenine to blunt ends using Klenow fragment (3’-5’ exo minus), Illumina genomic adapters were ligated and the sample was size-fractionated to 175–225 bp on a 2% agarose gel. After amplification for 18 cycles with Phusion polymerase, the resulting DNA libraries were tested by qPCR at the same specific genomic regions as the original ChIP DNA to assess quality of the amplification reactions

treatment_protocol: treated subcutaneously with oil/P4 for 1 hr

tag: tissue

value: uterus

value: 8 week

tag: strain

tag: chip antibody


title: BreastCancer_S006

status: Public on Jan 21 2014

type: RNA

city: Penzberg

first: Anton

last: Belousov

address: Nonnenwald 2

department: NCS-TTB

country: Germany

institute: Roche

hyb_protocol: Hybridization of labeled probes on the Affymetrix GeneChip Human Genome U133 Plus 2.0 Array were conducted using the GeneChip® Hybridization, Wash, and Stain Kit (Affymetrix).

scan_protocol: For this workflow a GeneChip Fluidics Station 450 and a GeneChip Scanner 3000 7G were used

label: biotin

molecule: total RNA

organism: Homo sapiens

source_name: breast cancer

label_protocol: A Transcriptor First Strand cDNA Synthesis Kit (Roche) was used to prepare cDNA from 100 ng of total RNA, using an anchored oligo(dT)-primer followed by a subsequent amplification step with the SYBR Green I Master on a LightCycler® 480 instrument (Roche Applied Science). Formalin-fixed paraffin-embedded tumor (FFPET)-derived RNA was amplified with the WT-Ovation™ FFPE System V2 (NuGEN). Biotin labeling of the cDNA was performed using the FL-Ovation cDNA Biotin Module V2 (NuGEN).

extract_protocol: Formalin-fixed, paraffin-embedded (FFPE) core biopsies were prospectively collected prior to treatment. The yield and purity of RNA was determined using a NanoDrop 1000 Spectrophotometer (Thermo Scientific). RNA integrity was measured using a Bioanalyzer (Agilent Technologies) with either the RNA Nano or Pico Kit, depending on sample concentration. The RNA Integrity Number (RIN) and average length of the RNA were used for sample characterization. mRNA integrity was measured using a semiquantitative reverse transcription-polymerase chain reaction assay (rtPCR). This assay is based on quantitative amplification of 5'- and 3'-end sequences of the housekeeping gene β-actin. Calculating the ratio of 3' to 5' amplicons allows for assessment of mRNA integrity: intact RNA transcripts exhibit a ratio of 1, while degraded RNA increases the ratio.

tag: centerid

tag: patid

tag: inflammatory_cells [%]

tag: invasive_tumor_area_size1 [mm]

tag: invasive_tumor_area_size2 [mm]

tag: invasive_tumor_cells [%]

tag: necrotic_cells [%]

tag: normal_epithelial_cells [%]

tag: preneoplastic_tumor_cells [%]

tag: stroma_cells [%]

tag: race

value: Caucasian

tag: er

value: ER+

tag: pr

value: PR-

tag: arm

value: HER2+ CT H

tag: treatment

value: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF) + Trastuzumab for 1 year

tag: age

tag: ecog

value: no

value: post

tag: pcr

value: RD


title: BreastCancer_S005

tag: centerid

tag: patid

value: HER2+ CT

value: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF)

value: pre

value: pCR


title: BreastCancer_S009

tag: inflammatory_cells [%]

tag: invasive_tumor_area_size1 [mm]

value: ER-


title: BreastCancer_S007

tag: invasive_tumor_area_size2 [mm]

tag: invasive_tumor_cells [%]

value: PR+


title: BreastCancer_S002

tag: necrotic_cells [%]

tag: normal_epithelial_cells [%]

value: yes


title: GATA2dd_P42

city: RTP

first: Franco

last: Demayo

state: NC

address: 111 TW Alexander Drive

country: USA

institute: NIEHS

description: Gene expression data from ovariectomized P4 treated Gata2 d/d uterus horn

hyb_protocol: The fragmented, labeled cRNA (15 ug) was hybridized to Affymetrix mouse genome 430 2.0 arrays.

scan_protocol: Scanning was done using an Affymetrix 3000 with autoloading scanner performed using Affymetrix protocols.

data_processing: A DNA-Chip analyzer dChIP version 1.3 was utilized to adjust arrays to a common baseline using invariant set normalization. All Genechips (n=6) were normalized together to the same baseline and modeled together.

organism: Mus musculus

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).

extract_protocol: QIAGEN RNeasy total RNA isolation kit.

tag: genotype/variation

value: GATA2 d/d

tag: gender

value: female

value: 8 weeks old

tag: strain

value: mixed background

tag: tissue

value: ovariectomized uterus


title: GATA2dd_Oil3

description: Gene expression data from ovariectomized Oil treated Gata2 d/d uterus horn


title: GATA2dd_Oil2


title: BreastCancer_S004

tag: preneoplastic_tumor_cells [%]

tag: stroma_cells [%]

tag: race

value: Caucasian

tag: er

tag: pr

value: PR-

tag: arm

value: HER2+ CT H


title: GATA2dd_Oil1

tag: age


title: GATA2dd_P43


title: renal allograft biopsy,  (U of A/Chicago)_INT304

status: Public on Sep 15 2013

city: Edmonton

first: Jessica

last: Chang

address: 250 Heritage Medical Research Centre

department: Medicine

country: Canada

institute: University of Alberta

hyb_protocol: Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C on GeneChip HGU133 Plus 2.0 Human Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.

scan_protocol: GeneChips were scanned using Gene Array Scanner (Affymetrix) and processed with GeneChip Operating Software Version 1.4.0 (Affynetrix).

data_processing: Microarray data files were preprocessed using robust multi-chip averaging (RMA) implemented in Bioconductor.

source_name: renal allograft biopsy

label_protocol: RNA (1-2µg) was labeled using GeneChip HT One-Cycle Target Labeling and Control kit. Quality of labeled cRNA was assessed on an Agilent 2100 Bioanalyzer (Agilent, Palo Alto, CA) before hybridization to HGU133Plus2.0. GeneChip (Affymetrix, Santa Clara, CA).

extract_protocol: Following homogenization of the tissue in 0.5ml of Trizol reagent (Invitrogen, Carlsbad, CA), total RNA was extracted and purified using the Rneasy Micro Kit (Quiagen, Ontario, Canada) (average yield 4µg/core, (RNA integrity number >7).

treatment_protocol:
All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.
The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.

value: renal allograft biopsy

value: non-TCMR

tag: histologic diagnosis (abmr, tcmr, bdl, mixed, others)

value: Others

tag: ah-lesion score (0, >0)


title: renal allograft biopsy,  (U of A/Chicago)_INT303


title: renal allograft biopsy,  (U of A/Chicago)_INT302

value: TCMR


title: renal allograft biopsy,  (U of A/Chicago)_INT306


title: renal allograft biopsy,  (U of A/Chicago)_INT305


title: GATA2dd_P41


title: renal allograft biopsy,  (U of A/Chicago)_INT300

value: ABMR


title: renal allograft biopsy,  (U of A/Chicago)_INT297


title: renal allograft biopsy,  (U of A/Chicago)_INT296


title: renal allograft biopsy,  (U of A/Chicago)_INT301


title: renal allograft biopsy,  (U of A/Chicago)_INT299


title: renal allograft biopsy,  (U of A/Chicago)_INT295


title: renal allograft biopsy,  (U of A/Chicago)_INT298

value: Borderline


title: renal allograft biopsy,  (U of A/Chicago)_INT294


title: renal allograft biopsy,  (U of A/Chicago)_INT293


title: renal allograft biopsy,  (U of A/Chicago)_INT291


title: renal allograft biopsy,  (U of A/Chicago)_INT284


title: renal allograft biopsy,  (U of A/Chicago)_INT289


title: renal allograft biopsy,  (U of A/Chicago)_INT285


title: renal allograft biopsy,  (U of A/Chicago)_INT281


title: renal allograft biopsy,  (U of A/Chicago)_INT276


title: renal allograft biopsy,  (U of A/Chicago)_INT282


title: renal allograft biopsy,  (U of A/Chicago)_INT290


title: renal allograft biopsy,  (U of A/Chicago)_INT279


title: renal allograft biopsy,  (U of A/Chicago)_INT277


title: renal allograft biopsy,  (U of A/Chicago)_INT287


title: BreastCancer_S015

tag: centerid

tag: patid

tag: inflammatory_cells [%]

tag: invasive_tumor_area_size1 [mm]

tag: invasive_tumor_area_size2 [mm]

value: ER-

value: HER2+ CT

tag: treatment

value: neoadjuvant doxorubicin/paclitaxel (AT) followed by cyclophosphamide/methotrexate/fluorouracil (CMF)

tag: ecog

value: no

value: post

tag: pcr

value: RD


title: renal allograft biopsy,  (U of A/Chicago)_INT274

tag: tissue


title: renal allograft biopsy,  (U of A/Chicago)_INT283


title: renal allograft biopsy,  (U of A/Chicago)_INT292


title: renal allograft biopsy,  (U of A/Chicago)_INT275


title: renal allograft biopsy,  (U of A/Chicago)_INT280


title: renal allograft biopsy,  (U of A/Chicago)_INT272


title: renal allograft biopsy,  (U of A/Chicago)_INT288


title: renal allograft biopsy,  (U of A/Chicago)_INT273


title: renal allograft biopsy,  (U of A/Chicago)_INT270


title: renal allograft biopsy,  (U of A/Chicago)_INT265


title: renal allograft biopsy,  (U of A/Chicago)_INT271


title: renal allograft biopsy,  (U of A/Chicago)_INT268


title: renal allograft biopsy,  (U of A/Chicago)_INT286


title: renal allograft biopsy,  (U of A/Chicago)_INT263


title: renal allograft biopsy,  (U of A/Chicago)_INT267


title: renal allograft biopsy,  (U of A/Chicago)_INT262


title: renal allograft biopsy,  (U of A/Chicago)_INT257


title: renal allograft biopsy,  (U of A/Chicago)_INT248


title: BreastCancer_S013

tag: invasive_tumor_cells [%]

tag: necrotic_cells [%]

tag: normal_epithelial_cells [%]

tag: preneoplastic_tumor_cells [%]

tag: stroma_cells [%]

value: ER+

value: pCR


title: renal allograft biopsy,  (U of A/Chicago)_INT264


title: renal allograft biopsy,  (U of A/Chicago)_INT253

value: Mixed


title: renal allograft biopsy,  (U of A/Chicago)_INT258


title: renal allograft biopsy,  (U of A/Chicago)_INT249


title: renal allograft biopsy,  (U of A/Chicago)_INT269


title: renal allograft biopsy,  (U of A/Chicago)_INT254


title: renal allograft biopsy,  (U of A/Chicago)_INT252


title: renal allograft biopsy,  (U of A/Chicago)_INT259


title: renal allograft biopsy,  (U of A/Chicago)_INT255


title: Nephrectomies (U of A)_INT260

source_name: Nephrectomy

value: nephrectomy

value: Nephrectomies


title: renal allograft biopsy,  (U of A/Chicago)_INT246

value: renal allograft biopsy


title: renal allograft biopsy,  (U of A/Chicago)_INT266


title: renal allograft biopsy,  (U of A/Chicago)_INT278

value: non-TCMR


title: renal allograft biopsy,  (U of A/Chicago)_INT251

value: Others


title: renal allograft biopsy,  (U of A/Chicago)_INT256

value: TCMR


title: Nephrectomies (U of A)_INT250


title: renal allograft biopsy,  (U of A/Chicago)_INT245


title: renal allograft biopsy,  (U of A/Chicago)_INT261


title: renal allograft biopsy,  (U of A/Chicago)_INT247


title: renal allograft biopsy,  (U of A/Chicago)_INT242

value: ABMR


title: renal allograft biopsy,  (U of A/Chicago)_INT237


title: renal allograft biopsy,  (U of A/Chicago)_INT240

value: Borderline


title: renal allograft biopsy,  (U of A/Chicago)_INT235


title: renal allograft biopsy,  (U of A/Chicago)_INT244


title: renal allograft biopsy,  (U of A/Chicago)_INT243


title: renal allograft biopsy,  (U of A/Chicago)_INT238


title: renal allograft biopsy,  (U of A/Chicago)_INT236


title: renal allograft biopsy,  (U of A/Chicago)_INT239


title: renal allograft biopsy,  (U of A/Chicago)_INT233


title: renal allograft biopsy,  (U of A/Chicago)_INT225


title: renal allograft biopsy,  (U of A/Chicago)_INT230


title: renal allograft biopsy,  (U of A/Chicago)_INT232


title: renal allograft biopsy,  (U of A/Chicago)_INT228


title: renal allograft biopsy,  (U of A/Chicago)_INT231


title: renal allograft biopsy,  (U of A/Chicago)_INT227


title: INT223


title: renal allograft biopsy,  (U of A/Chicago)_INT226


title: INT221


title: renal allograft biopsy,  (U of A/Chicago)_INT224


title: INT218


title: INT219


title: INT217


title: INT222


title: INT215


title: INT216


title: INT220


title: renal allograft biopsy,  (U of A/Chicago)_INT229


title: renal allograft biopsy,  (U of A/Chicago)_INT234


title: INT214


title: INT211


title: INT212


title: INT213


title: INT210


title: INT208


title: INT203


title: INT206


title: INT202


title: INT201


title: INT200


title: INT199


title: INT205


title: INT204


title: INT207


title: INT196


title: INT209


title: INT194


title: INT193


title: INT195


title: INT186


title: INT192


title: INT197


title: INT198


title: INT191


title: INT187


title: INT190


title: INT188


title: INT189


title: INT185


title: INT181


title: INT175


title: INT174


title: INT180


title: INT182


title: INT178


title: INT172


title: INT184


title: INT170


title: INT183


title: INT177


title: INT169


title: renal allograft biopsy,  (U of A/Chicago)_INT241


title: INT161


title: INT165


title: INT163


title: INT162


title: INT167


title: INT176


title: INT179


title: INT160


title: INT164


title: INT173


title: INT168


title: INT171


title: INT166


title: INT158


title: INT157


title: INT159


title: INT155


title: INT149


title: INT154


title: INT151


title: INT148


title: INT145


title: INT144


title: INT153


title: INT156


title: INT142


title: INT139


title: INT150


title: INT140


title: INT143


title: INT147


title: INT146


title: INT152


title: INT141


title: INT138


title: INT137


title: INT136


title: INT133


title: INT132


title: INT127


title: INT134


title: INT131


title: INT128


title: INT135


title: INT122


title: INT125


title: INT126


title: INT115


title: INT113


title: INT112


title: INT123


title: INT121


title: INT117


title: INT124


title: INT119


title: INT108


title: INT129


title: INT118


title: INT107


title: INT130


title: INT116


title: INT120


title: INT110


title: INT111


title: INT109


title: INT106


title: INT100


title: INT114


title: INT105


title: INT104


title: INT99


title: INT101


title: INT102


title: INT96


title: INT103


title: INT95


title: INT98


title: INT94


title: INT92


title: INT91


title: INT97


title: INT87


title: INT89


title: INT84


title: INT82


title: INT81


title: INT78


title: INT77


title: INT93


title: INT80


title: INT88


title: INT86


title: INT83


title: INT79


title: INT85


title: INT90


title: INT71


title: INT72


title: INT75


title: INT73


title: INT68


title: INT67


title: INT66


title: INT76


title: INT70


title: INT60


title: INT69


title: INT62


title: INT63


title: INT59


title: INT74


title: INT58


title: INT53


title: INT57


title: INT52


title: INT65


title: INT64


title: INT61


title: INT56


title: INT51


title: INT55


title: INT49


title: INT54


title: INT47


title: INT50


title: INT48


title: INT36


title: INT43


title: INT39


title: INT44


title: INT40


title: INT45


title: INT37


title: INT32


title: INT41


title: INT35


title: INT46


title: INT42


title: INT31


title: INT26


title: INT28


title: INT29


title: INT23


title: INT25


title: INT18


title: INT27


title: INT22


title: INT38


title: INT34


title: INT30


title: INT21


title: INT19


title: INT24


title: INT20


title: INT33


title: INT17


title: INT15


title: INT14


title: INT16


title: INT13


title: C4 RNA-Seq

status: Public on Jun 01 2013

type: SRA

city: Nijmegen

first: Jo Huiqing

last: Zhou

address: Geert Grooteplein 26/28

country: Netherlands

institute: Radboud University

library_source: transcriptomic

data_processing:
RNA-seq reads were mapped to the hg19 reference genome using Bowtie version 0.12.7 with a SNP fraction of 0.001.
Mapped reads were assigned to transcripts of the March 9 2012 version of the Illumina iGenomes transcriptome (http://cufflinks.cbcb.umd.edu/igenomes.html) using HTSeq (http://www-huber.embl.de/users/anders/HTSeq/) version 0.5.3p9 with default settings.
Differential expression between patients and controls was determined using the count-based DESeq R package. A Benjamini & Hochberg multiple testing-adjusted P-value cut-off of 0.05 was used.
Gene expression levels were calculated as the DESeq-normalized number of reads per kilobase of gene exon model length (normalized reads per kilobase; NRPK). Gene exon model length was determined by overlapping the genomic ranges of all exons assigned to a gene in the iGenomes GTF file with BedTools, and summing up their total genomic coverage. The NRPK value was scaled to a “reads per kilobase per million mapped reads” (RPKM) value by dividing it by the mean number of reads per individual in millions.
Genome_build: hg19
Supplementary_files_format_and_content: Tab-separated RPKM expression matrix containing gene Ensembl ID, Entrez gene ID, HUGO gene symbol, and the RPKM values for the 3 patients and 8 controls. Where one measurement corresponds to multiple gene IDs, these are sepatered by semicolons.

source_name: Blood lymphocytes

extract_protocol:
Blood lymphocytes were extracted using the PAXgeneTM Blood System (Becton Dickinson, Heidelberg, Germany). 20 ng total RNA was amplified using the Ovation RNA-Seq system (NuGEN, San Carlos, CA, USA).
The Beckman Coulter SPRIworks (Beckman Coulter, Danvers, MA, USA) platform was used for the automated library preparation.

tag: individual type

value: control

tag: gender

value: male

tag: mutation type

tag: cell type

value: blood lymphocyte

tag: phenotype


title: C7 RNA-Seq

value: female


title: C3 RNA-Seq


title: C6 RNA-Seq


title: P3 RNA-Seq

value: patient

value: Missense

value: intellectual disability


title: C5 RNA-Seq


title: C2 RNA-Seq


title: P1 RNA-Seq

value: Frame shift


title: C8 RNA-Seq


title: C1 RNA-Seq


title: C4 ChIP-Seq

library_source: genomic

data_processing:
Reads were mapped to the human GRCh37 genome (hg19; assembly February 2009) using BWA 0.6.1 with standard parameters.
All duplicate reads and reads mapping to repeat regions were removed.
Peaks were called using MACS 1.4.2 with default settings, with the ENCODE UW Gm12878 lymphoblastoid cell line ChIP-seq input track used as background control.
Gm12878 control input track is a publicly available data set generated at the University of Washington as part of the international ENCODE project (http://www.genome.gov/10005107).
Genome_build: hg19
Supplementary_files_format_and_content: MACS output files; an .txt file with peak data and a .bed file with peak scores

molecule: genomic DNA

extract_protocol:
Lymphocytes were isolated from 10 ml Heparin blood using a swelling buffer (155 mM NH4CL2, 10 mM KHCO3, 0,01 mM EDTA) to disrupt erythrocytes.
Cells were cross-linked in 1% formaldehyde for 10 min at room temperature. Chromatin was sonicated using a Bioruptor sonicator (Diagenode, Liège, Belgium) for 28 minutes at high power, 30 s ON, 30 s OFF, and ChIP was performed using a CTCF antibody (Millipore, Billerica, MA, USA; 07-729). 7 ng of DNA as measured by Qubit (Life Technologies) was prepared for sequencing. A barcoded NEXTflex adaptor was ligated to the DNA fragments, and fragments with adaptors were amplified by a pre-size selection PCR of 4 cycles, followed by size selection (∼300 bp) and further amplification by 14 PCR cycles. Three barcoded samples were sequenced in one lane on a HiSeq 2000 (Illumina, San Diego, CA, USA). The reads were demultiplexed using CASAVA 1.8.2 (Illumina).


title: INT6

tag: histologic diagnosis (abmr, tcmr, bdl, mixed, others)

tag: ah-lesion score (0, >0)


title: P2 RNA-Seq


title: INT1


title: INT3


title: INT7


title: INT4


title: INT10


title: INT12


title: INT11


title: INT8


title: INT9


title: INT5


title: OXFU_410

status: Public on Mar 21 2013

city: Winston-Salem

first: Jeff

last: Chou

address: Medical Center Blvd

institute: Atrium Health Wake Forest Baptist

description:
OXFU_410
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

hyb_protocol: The standard Affymetrix GeneChip hyridization protocol was followed.

scan_protocol: The standard Affymetrix GeneChip scanning protocol was followed.

data_processing: The raw data were normalized by using MAS5 and batch-corrected by using Combat

source_name: Breast tumor

label_protocol: Five micrograms of total RNA was used to generate cRNA (target) according to the standard Affymetrix (3' IVT) protocol.

extract_protocol: Tumor specimens from the IJB and JRH we processed and profiled at the IJB (Christos Sotiriou). Specimens from the NUH were processed and profiled at the Genome Institute of Singapore. Total RNA was extracted from fozen tumor specimens by the Trizol method, cleaned on Qiagen RNeasy columns and analyzed for integrity on the Agilent Bioanalyzer.

tag: ln status

value: LN-

tag: er status

value: ER-

tag: pgr status

tag: her2 status

tag: histological grade

tag: size (mm)

tag: patient age

tag: histology

tag: adjuvant treated? (0=no, 1=yes)

tag: characteristics

value: endocrine? (0=no, 1=yes):0

tag: chemo? (0=no, 1=yes)

tag: treatment type

tag: dfs time

tag: dfs event (defined as any type of recurrence or death from breast cancer)

tag: dmfs time

tag: dmfs event (defined as distant metastasis or death from breast cancer)

tag: DSS time

tag: dss event (defined as death from breast cancer)


title: OXFU_554

description:
OXFU_554
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: ln status

tag: er status

value: ER+


title: 98_8377

description:
IJB_5467
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: pgr status

value: PgR+

tag: her2 status

value: He+

value: endocrine? (0=no, 1=yes):1

value: Tamoxifen


title: 98_176

description:
IJB_5464
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: PgR-

tag: histological grade

tag: size (mm)


title: OXFU_369

description:
OXFU_369
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: patient age

tag: histology


title: 98_301

description:
IJB_5466
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: He-

tag: adjuvant treated? (0=no, 1=yes)

tag: characteristics

value: CMFx6; Tamoxifen


title: 97_12101

description:
IJB_5465
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: chemo? (0=no, 1=yes)

tag: treatment type


title: 98_2095

description:
IJB_5468
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: dfs time

tag: dfs event (defined as any type of recurrence or death from breast cancer)


title: 97_9201

description:
IJB_5463
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: dmfs time

tag: dmfs event (defined as distant metastasis or death from breast cancer)


title: 01_1620

description:
IJB_5469
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: DSS time

tag: dss event (defined as death from breast cancer)


title: 97_5410

description:
IJB_5459
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: ln status

tag: er status

value: ACx4; Arimidex/Tamoxifen


title: 96_8234

description:
IJB_5453
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: pgr status

tag: her2 status


title: 97_10569

description:
IJB_5462
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: histological grade

tag: size (mm)


title: 97_10321

description:
IJB_5461
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: patient age

tag: histology


title: 97_3340

description:
IJB_5458
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: adjuvant treated? (0=no, 1=yes)

tag: characteristics


title: 96_9210

description:
IJB_5455
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: chemo? (0=no, 1=yes)

tag: treatment type


title: 96_14641

description:
IJB_5454
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: dfs time

tag: dfs event (defined as any type of recurrence or death from breast cancer)


title: 96_12695

description:
IJB_5456
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: endocrine? (0=no, 1=yes):NA

tag: dmfs time

tag: dmfs event (defined as distant metastasis or death from breast cancer)


title: 95_11893

description:
IJB_5447
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: DSS time

tag: dss event (defined as death from breast cancer)


title: 96_2614

description:
IJB_5451
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: ln status

tag: er status

value: ACx6; Tamoxifen


title: 95_6413

description:
IJB_5446
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: pgr status

tag: her2 status


title: 96_4793

description:
IJB_5448
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: histological grade

tag: size (mm)

value: ACx4; Tamoxifen


title: 96_3132

description:
IJB_5452
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: patient age

tag: histology


title: 95_5029

description:
IJB_5444
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: adjuvant treated? (0=no, 1=yes)

tag: characteristics


title: 97_7954

description:
IJB_5460
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: chemo? (0=no, 1=yes)

tag: treatment type

value: CMFx6; Arimidex/Tamoxifen


title: 97_938

description:
IJB_5449
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: dfs time

tag: dfs event (defined as any type of recurrence or death from breast cancer)


title: 94_14421

description:
IJB_5445
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: Tamoxifen+Zoledronic acid

tag: dmfs time

tag: dmfs event (defined as distant metastasis or death from breast cancer)


title: 98_478

description:
IJB_5443
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: LN-

value: Arimidex/Tamoxifen

tag: DSS time

tag: dss event (defined as death from breast cancer)


title: 97_1564

description:
IJB_5457
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: ln status

tag: er status

value: endocrine? (0=no, 1=yes):0


title: 96_1378

description:
IJB_5441
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: ER+

tag: pgr status

tag: her2 status


title: INT2

tag: tissue

value: renal allograft biopsy

value: non-TCMR

tag: histologic diagnosis (abmr, tcmr, bdl, mixed, others)

value: Others

tag: ah-lesion score (0, >0)


title: 97_2927

description:
IJB_5442
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: PgR+

tag: histological grade

tag: size (mm)

tag: patient age

tag: histology

tag: adjuvant treated? (0=no, 1=yes)

value: endocrine? (0=no, 1=yes):1

value: CMFx2; Tamoxifen


title: 96_3800

description:
IJB_5450
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: PgR-

value: He+

tag: characteristics

tag: chemo? (0=no, 1=yes)

tag: treatment type

value: Tamoxifen

tag: dfs time

tag: dfs event (defined as any type of recurrence or death from breast cancer)


title: 95_5655

description:
IJB_5440
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: ln status

value: ER-

value: He-

tag: dmfs time

tag: dmfs event (defined as distant metastasis or death from breast cancer)

tag: DSS time

tag: dss event (defined as death from breast cancer)


title: 95_9670

description:
IJB_5430
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: er status

tag: pgr status

tag: her2 status

value: CMFx6; Tamoxifen


title: 97_6230

description:
IJB_5435
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: histological grade

tag: size (mm)

value: ECx4; Tamoxifen


title: 97_2461

description:
IJB_5434
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: LN-

tag: patient age

tag: histology


title: 98_1467

description:
IJB_5437
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: adjuvant treated? (0=no, 1=yes)

tag: characteristics


title: 97_4970

description:
IJB_5433
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: chemo? (0=no, 1=yes)

tag: treatment type


title: NUH.BT099

description:
SIN_BT099
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: LN+

value: invasive ductal carcinoma

value: Tam+CMFx6 cycles

tag: dfs time

tag: dfs event (defined as any type of recurrence or death from breast cancer)


title: 00_4773

description:
IJB_5438
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: ln status

value: ER+

tag: dmfs time


title: 97_10495

description:
IJB_5436
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: dmfs event (defined as distant metastasis or death from breast cancer)

tag: DSS time


title: 95_1279

description:
IJB_5429
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: er status

tag: dss event (defined as death from breast cancer)


title: NUH.BT008

description:
SIN_BT008
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: pgr status

tag: her2 status

value: Tam+AC


title: NUH.BT065

description:
SIN_BT065
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: histological grade

tag: size (mm)

value: endocrine? (0=no, 1=yes):0

value: ACx4 cycles


title: NUH.BT064

description:
SIN_BT064
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: patient age

tag: histology

value: endocrine? (0=no, 1=yes):1


title: NUH.BT091

description:
SIN_BT091
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: PgR+

tag: adjuvant treated? (0=no, 1=yes)

tag: characteristics

value: tamoxifen


title: 96_8645

description:
IJB_5432
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: PgR-

tag: chemo? (0=no, 1=yes)

tag: treatment type


title: NUH.BT072

description:
SIN_BT072
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: He+

value: medullary carcinoma

tag: dfs time

tag: dfs event (defined as any type of recurrence or death from breast cancer)


title: NUH.BT089

description:
SIN_BT089
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: ln status

value: He-

value: Tam+ACx4 cycles

tag: dmfs time


title: 97_3659

description:
IJB_5439
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: Tamoxifen+Zoledronic acid

tag: dmfs event (defined as distant metastasis or death from breast cancer)

tag: DSS time


title: NUH.BT082

description:
SIN_BT082
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: LN-

tag: er status

tag: dss event (defined as death from breast cancer)


title: NUH.BT062

description:
SIN_BT062
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: ER-

tag: pgr status

tag: her2 status


title: NUH.BT084

description:
SIN_BT084
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: histological grade

tag: size (mm)

value: invasive ductal carcinoma and papillary carcinoma


title: 96_6784

description:
IJB_5431
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: patient age

tag: histology

value: Tamoxifen


title: NUH.BT092

description:
SIN_BT092
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: LN+

value: ER+

value: invasive ductal carcinoma

tag: adjuvant treated? (0=no, 1=yes)

tag: characteristics

value: endocrine? (0=no, 1=yes):NA


title: NUH.BT077

description:
SIN_BT077
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: endocrine? (0=no, 1=yes):1

tag: chemo? (0=no, 1=yes)

tag: treatment type


title: NUH.BT007

description:
SIN_BT007
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: PgR+

tag: dfs time

tag: dfs event (defined as any type of recurrence or death from breast cancer)


title: NUH.BT066

description:
SIN_BT066
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: ln status

tag: dmfs time


title: NUH.BT071

description:
SIN_BT071
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: endocrine? (0=no, 1=yes):0

value: CAF

tag: dmfs event (defined as distant metastasis or death from breast cancer)

tag: DSS time


title: NUH.BT060

description:
SIN_BT060
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: er status

value: PgR-

value: He+

value: ACx4 cycles

tag: dss event (defined as death from breast cancer)


title: NUH.BT073

description:
SIN_BT073
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: pgr status

tag: her2 status

value: Tam+ACx4 cycles


title: NUH.BT076

description:
SIN_BT076
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: He-

tag: histological grade

tag: size (mm)

value: invasive lobular carcinoma

value: tamoxifen


title: NUH.BT063

description:
SIN_BT063
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: LN-

value: ER-

tag: patient age

tag: histology


title: NUH.BT056

description:
SIN_BT056
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: adjuvant treated? (0=no, 1=yes)

tag: characteristics


title: NUH.BT059

description:
SIN_BT059
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: LN+

tag: chemo? (0=no, 1=yes)

tag: treatment type

value: CAFx6 cycles


title: NUH.BT006

description:
SIN_BT006
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: ER+

value: invasive ductal carcinoma

value: Tam+CMFx6 cycles

tag: dfs time

tag: dfs event (defined as any type of recurrence or death from breast cancer)


title: NUH.BT051

description:
SIN_BT051
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: ln status

value: PgR+

value: endocrine? (0=no, 1=yes):1

tag: dmfs time


title: NUH.BT053

description:
SIN_BT053
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: endocrine? (0=no, 1=yes):0

value: CMF

tag: dmfs event (defined as distant metastasis or death from breast cancer)

tag: DSS time


title: NUH.BT050

description:
SIN_BT050
not included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: er status

value: papillary carcinoma

tag: dss event (defined as death from breast cancer)


title: NUH.BT052

description:
SIN_BT052
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: pgr status

value: PgR-

tag: her2 status

value: medullary carcinoma


title: NUH.BT041

description:
SIN_BT041
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: He+

tag: histological grade

tag: size (mm)

value: Tam+ACx4 cycles


title: NUH.BT045

description:
SIN_BT045
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: patient age

tag: histology

value: ACx4 cycles


title: NUH.BT043

description:
SIN_BT043
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: LN-

value: He-

tag: adjuvant treated? (0=no, 1=yes)

tag: characteristics


title: NUH.BT040

description:
SIN_BT040
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: ER-

tag: chemo? (0=no, 1=yes)

tag: treatment type


title: NUH.BT013

description:
SIN_BT013
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: LN+

value: CAF

tag: dfs time

tag: dfs event (defined as any type of recurrence or death from breast cancer)


title: NUH.BT020

description:
SIN_BT020
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: ln status

value: ER+

value: invasive ductal carcinoma

value: tamoxifen

tag: dmfs time


title: NUH.BT033

description:
SIN_BT033
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: endocrine? (0=no, 1=yes):NA

tag: dmfs event (defined as distant metastasis or death from breast cancer)

tag: DSS time


title: NUH.BT037

description:
SIN_BT037
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: er status

value: PgR+

value: invasive lobular carcinoma

value: endocrine? (0=no, 1=yes):0

value: CAFx6 cycles

tag: dss event (defined as death from breast cancer)


title: NUH.BT039

description:
SIN_BT039
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: pgr status

value: PgR-

tag: her2 status


title: NUH.BT003

description:
SIN_BT003
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: histological grade

tag: size (mm)


title: NUH.BT036

description:
SIN_BT036
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: patient age

tag: histology

value: endocrine? (0=no, 1=yes):1


title: NUH.BT034

description:
SIN_BT034
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: He+

tag: adjuvant treated? (0=no, 1=yes)

tag: characteristics


title: NUH.BT002

description:
SIN_BT002
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: chemo? (0=no, 1=yes)

tag: treatment type


title: NUH.BT005

description:
SIN_BT005
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: dfs time

tag: dfs event (defined as any type of recurrence or death from breast cancer)


title: NUH.BT004

description:
SIN_BT004
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: ln status

value: AC

tag: dmfs time


title: NUH.BT016

description:
SIN_BT016
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: dmfs event (defined as distant metastasis or death from breast cancer)

tag: DSS time


title: NUH.BT015

description:
SIN_BT015
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: er status

value: Arimidex+CMFx2 cycles

tag: dss event (defined as death from breast cancer)


title: NUH.BT110

description:
SIN_BT110
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: pgr status

tag: her2 status

value: ACx4 cycles


title: NUH.BT017

description:
SIN_BT017
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: LN-

value: ER-

tag: histological grade

tag: size (mm)


title: NUH.BT107

description:
SIN_BT107
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: patient age

tag: histology


title: NUH.BT012

description:
SIN_BT012
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: LN+

tag: adjuvant treated? (0=no, 1=yes)

tag: characteristics


title: NUH.BT117

description:
SIN_BT117
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: chemo? (0=no, 1=yes)

tag: treatment type


title: NUH.BT120

description:
SIN_BT120
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: ER+

tag: dfs time

tag: dfs event (defined as any type of recurrence or death from breast cancer)


title: NUH.BT048

description:
SIN_BT048
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: ln status

value: invasive ductal carcinoma

value: Tam+ACx4 cycles

tag: dmfs time


title: NUH.BT100

description:
SIN_BT100
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: tamoxifen

tag: dmfs event (defined as distant metastasis or death from breast cancer)

tag: DSS time


title: NUH.BT038

description:
SIN_BT038
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: er status

value: PgR+

value: ACx8 cycles; taxol

tag: dss event (defined as death from breast cancer)


title: NUH.BT112

description:
SIN_BT112
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: pgr status

tag: her2 status


title: NUH.BT101

description:
SIN_BT101
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: He-

tag: histological grade

tag: size (mm)

value: endocrine? (0=no, 1=yes):0

value: CAF


title: NUH.BT102

description:
SIN_BT102
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: patient age

tag: histology

value: mucinous carcinoma

value: endocrine? (0=no, 1=yes):1


title: NUH.BT010

description:
SIN_BT010
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

tag: adjuvant treated? (0=no, 1=yes)

tag: characteristics

value: tamoxifen;goserelin


title: NUH.BT001

description:
SIN_BT001
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013

value: PgR-

value: He+

tag: chemo? (0=no, 1=yes)

tag: treatment type


title: NUH.BT119

description:
SIN_BT119
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119977

value: LN-

value: ACx4 cycles

tag: dfs time

tag: dfs event (defined as any type of recurrence or death from breast cancer)


title: NUH.BT113

description:
SIN_BT113
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119975

tag: ln status

tag: dmfs time


title: NUH.BT114

description:
SIN_BT114
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119976

tag: dmfs event (defined as distant metastasis or death from breast cancer)

tag: DSS time


title: NUH.BT108

description:
SIN_BT108
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119973

value: LN+

tag: er status

value: ER-

value: invasive ductal and lobular carcinoma

value: endocrine? (0=no, 1=yes):NA

tag: dss event (defined as death from breast cancer)


title: NUH.BT096

description:
SIN_BT096
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119969

value: ER+

tag: pgr status

tag: her2 status

value: invasive ductal carcinoma

value: Tam+CAFx2 cycles


title: NUH.BT111

description:
SIN_BT111
not included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119974

value: PgR+

tag: histological grade

tag: size (mm)


title: NUH.BT103

description:
SIN_BT103
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119971

value: He-

tag: patient age

tag: histology

value: Tam+CMFx6 cycles


title: NUH.BT097

description:
SIN_BT097
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119970

tag: adjuvant treated? (0=no, 1=yes)

tag: characteristics


title: NUH.BT095

description:
SIN_BT095
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119968

value: endocrine? (0=no, 1=yes):0

tag: chemo? (0=no, 1=yes)

tag: treatment type


title: NUH.BT086

description:
SIN_BT086
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119962

value: endocrine? (0=no, 1=yes):1

value: Tam+ACx4 cycles

tag: dfs time

tag: dfs event (defined as any type of recurrence or death from breast cancer)


title: NUH.BT104

description:
SIN_BT104
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119972

tag: ln status

value: tamoxifen

tag: dmfs time


title: NUH.BT094

description:
SIN_BT094
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119967

tag: dmfs event (defined as distant metastasis or death from breast cancer)

tag: DSS time


title: NUH.BT090

description:
SIN_BT090
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119965

tag: er status

value: CAF

tag: dss event (defined as death from breast cancer)


title: NUH.BT087

description:
SIN_BT087
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119963

tag: pgr status

tag: her2 status

value: He+


title: NUH.BT093

description:
SIN_BT093
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119966

value: LN-

tag: histological grade

tag: size (mm)


title: NUH.BT083

description:
SIN_BT083
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119960

tag: patient age

tag: histology


title: NUH.BT049

description:
SIN_BT049
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119950

value: LN+

tag: adjuvant treated? (0=no, 1=yes)

tag: characteristics

value: CMF


title: NUH.BT067

description:
SIN_BT067
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119955

tag: chemo? (0=no, 1=yes)

tag: treatment type


title: NUH.BT078

description:
SIN_BT078
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119959

value: ER-

value: PgR-

tag: dfs time

tag: dfs event (defined as any type of recurrence or death from breast cancer)


title: NUH.BT054

description:
SIN_BT054
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119951

tag: ln status

value: ER+

tag: dmfs time


title: NUH.BT047

description:
SIN_BT047
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119949

value: invasive ductal carcinoma

tag: dmfs event (defined as distant metastasis or death from breast cancer)

tag: DSS time


title: NUH.BT074

description:
SIN_BT074
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119958

tag: er status

tag: dss event (defined as death from breast cancer)


title: NUH.BT061

description:
SIN_BT061
not included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119954

tag: pgr status

tag: her2 status


title: NUH.BT088

description:
SIN_BT088
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119964

tag: histological grade

tag: size (mm)


title: NUH.BT046

description:
SIN_BT046
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119948

tag: patient age

tag: histology


title: NUH.BT068

description:
SIN_BT068
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119956

tag: adjuvant treated? (0=no, 1=yes)

tag: characteristics

value: Tam+CAFx6 cycles


title: NUH.BT070

description:
SIN_BT070
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119957

value: invasive lobular carcinoma

tag: chemo? (0=no, 1=yes)

tag: treatment type

value: anastrozole;taxol


title: NUH.BT042

description:
SIN_BT042
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119947

value: He-

tag: dfs time

tag: dfs event (defined as any type of recurrence or death from breast cancer)


title: NUH.BT055

description:
SIN_BT055
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119952

tag: ln status

value: PgR+

value: Tam+CMFx6 cycles

tag: dmfs time


title: NUH.BT035

description:
SIN_BT035
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119946

value: endocrine? (0=no, 1=yes):0

tag: dmfs event (defined as distant metastasis or death from breast cancer)

tag: DSS time


title: NUH.BT029

description:
SIN_BT029
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119944

tag: er status

value: ACx4 cycles

tag: dss event (defined as death from breast cancer)


title: NUH.BT031

description:
SIN_BT031
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119945

tag: pgr status

tag: her2 status

value: endocrine? (0=no, 1=yes):NA


title: NUH.BT023

description:
SIN_BT023
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119943

value: He+

tag: histological grade

tag: size (mm)

value: endocrine? (0=no, 1=yes):1

value: tamoxifen


title: NUH.BT014

description:
SIN_BT014
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119939

value: LN+

tag: patient age

tag: histology


title: NUH.BT019

description:
SIN_BT019
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119941

value: LN-

tag: adjuvant treated? (0=no, 1=yes)

tag: characteristics


title: NUH.BT018

description:
SIN_BT018
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119940

tag: chemo? (0=no, 1=yes)

tag: treatment type


title: NUH.BT022

description:
SIN_BT022
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119942

tag: dfs time

tag: dfs event (defined as any type of recurrence or death from breast cancer)


title: NUH.BT009

description:
SIN_BT009
included in study population (n=1,954) of Nagalla, et. al., Genome Biology, 2013
reanalysis of:
GSM119938

tag: ln status

value: Tam+ACx4 cycles

tag: dmfs time


title: ABMR65

status: Public on Feb 13 2013

growth_protocol: All human renal allograft biopsies taken for clinical indication during the period specified above were included. Tissue was immediately placed in RNA later.

treatment_protocol: The immunosuppressive treatment of the patients before the biopsy was based on individual treatment regiments; the treatment after the biopsy was adjusted based on the histopathological diagnosis.

value: ABMR

tag: histologic diagnosis (abmr, tcmr, bdl, mixed, others)

tag: ah-lesion score (0, >0)


title: MIXED21

value: MIXED

value: Mixed


title: TCMR35

value: TCMR


title: ABMR15


title: non-rejecting271

value: non-rejecting

value: Others


title: non-rejecting143


title: non-rejecting145


title: ABMR64


title: ABMR16


title: ABMR17


title: non-rejecting104

value: Borderline


title: non-rejecting179


title: non-rejecting103


title: non-rejecting102


title: MIXED22


title: non-rejecting49


title: non-rejecting144


title: non-rejecting251


title: non-rejecting50


title: non-rejecting101


title: non-rejecting250


title: ABMR14


title: non-rejecting100


title: non-rejecting176


title: non-rejecting247


title: non-rejecting270


title: non-rejecting175


title: non-rejecting249


title: non-rejecting177


title: TCMR34


title: non-rejecting246


title: non-rejecting268


title: non-rejecting178


title: non-rejecting248


title: non-rejecting269


title: TCMR33


title: TCMR31


title: non-rejecting245


title: non-rejecting46


title: non-rejecting242


title: ABMR63


title: non-rejecting241


title: TCMR32


title: non-rejecting44


title: non-rejecting174


title: non-rejecting173


title: non-rejecting243


title: non-rejecting40


title: TCMR30


title: ABMR62


title: non-rejecting47


title: non-rejecting45


title: non-rejecting43


title: non-rejecting48


title: non-rejecting42


title: non-rejecting244


title: non-rejecting41


title: non-rejecting240


title: non-rejecting140


title: non-rejecting266


title: non-rejecting142


title: non-rejecting39


title: non-rejecting98


title: non-rejecting239


title: non-rejecting97


title: non-rejecting99


title: non-rejecting62


title: non-rejecting238


title: non-rejecting59


title: non-rejecting265


title: non-rejecting236


title: non-rejecting139


title: non-rejecting61


title: TCMR29


title: ABMR61


title: non-rejecting237


title: ABMR13


title: non-rejecting60


title: non-rejecting235


title: ABMR60


title: non-rejecting231


title: non-rejecting38


title: ABMR59


title: non-rejecting95


title: non-rejecting58


title: non-rejecting96


title: non-rejecting234


title: non-rejecting172


title: non-rejecting233


title: non-rejecting232


title: non-rejecting229


title: non-rejecting141


title: non-rejecting228


title: non-rejecting281


title: non-rejecting230


title: ABMR58


title: ABMR12


title: non-rejecting170


title: non-rejecting94


title: non-rejecting226


title: non-rejecting36


title: non-rejecting37


title: non-rejecting227


title: non-rejecting171


title: MIXED20


title: non-rejecting225


title: Nephrectomy8

source_name: nephrectomy

value: Nephrectomy


title: non-rejecting93


title: non-rejecting224


title: non-rejecting167


title: TCMR28


title: non-rejecting169


title: MIXED17


title: ABMR11


title: MIXED18


title: non-rejecting168


title: non-rejecting34


title: MIXED19


title: non-rejecting138


title: non-rejecting92


title: TCMR27


title: non-rejecting91


title: non-rejecting90


title: non-rejecting35


title: TCMR26


title: non-rejecting264


title: non-rejecting166


title: non-rejecting57


title: non-rejecting89


title: TCMR25


title: non-rejecting56


title: TCMR24


title: ABMR10


title: non-rejecting222


title: non-rejecting223


title: non-rejecting221


title: non-rejecting218


title: non-rejecting220


title: non-rejecting280


title: non-rejecting86


title: non-rejecting219


title: non-rejecting267


title: non-rejecting136


title: ABMR9


title: non-rejecting137


title: non-rejecting88


title: non-rejecting217


title: TCMR23


title: non-rejecting55


title: non-rejecting32


title: non-rejecting33


title: non-rejecting135


title: MIXED16


title: non-rejecting85


title: non-rejecting87


title: non-rejecting134


title: non-rejecting263


title: non-rejecting31


title: non-rejecting165


title: non-rejecting164


title: ABMR56


title: non-rejecting84


title: non-rejecting133


title: Nephrectomy7


title: non-rejecting128


title: TCMR20


title: TCMR22


title: non-rejecting130


title: TCMR19


title: ABMR57


title: MIXED15


title: ABMR55


title: non-rejecting83


title: non-rejecting279


title: TCMR21


title: TCMR18


title: ABMR8


title: non-rejecting131


title: non-rejecting216


title: TCMR17


title: non-rejecting129


title: non-rejecting215


title: non-rejecting54


title: non-rejecting132


title: ABMR54


title: Nephrectomy6


title: non-rejecting213


title: non-rejecting214


title: ABMR52


title: non-rejecting30


title: non-rejecting82


title: non-rejecting29


title: ABMR51


title: non-rejecting80


title: non-rejecting163


title: non-rejecting127


title: non-rejecting126


title: non-rejecting81


title: non-rejecting212


title: TCMR15


title: non-rejecting278


title: non-rejecting125


title: non-rejecting211


title: non-rejecting277


title: non-rejecting276


title: non-rejecting210


title: ABMR7


title: non-rejecting28


title: MIXED14


title: TCMR14


title: non-rejecting79


title: non-rejecting27


title: non-rejecting122


title: TCMR16


title: ABMR50


title: MIXED13


title: ABMR49


title: non-rejecting124


title: non-rejecting275


title: non-rejecting123


title: non-rejecting207


title: non-rejecting78


title: ABMR53


title: non-rejecting262


title: non-rejecting208


title: MIXED12


title: non-rejecting209


title: non-rejecting25


title: non-rejecting24


title: non-rejecting121


title: non-rejecting206


title: TCMR13


title: TCMR12


title: non-rejecting53


title: non-rejecting26


title: non-rejecting22


title: non-rejecting23


title: non-rejecting204


title: non-rejecting21


title: ABMR5


title: non-rejecting203


title: non-rejecting256


title: non-rejecting259


title: non-rejecting257


title: non-rejecting258


title: non-rejecting17


title: non-rejecting19


title: non-rejecting20


title: non-rejecting260


title: ABMR6


title: non-rejecting117


title: non-rejecting205


title: non-rejecting118


title: non-rejecting202


title: TCMR11


title: ABMR48


title: non-rejecting120


title: non-rejecting77


title: non-rejecting18


title: non-rejecting116


title: non-rejecting162


title: non-rejecting76


title: non-rejecting119


title: MIXED11


title: TCMR10


title: non-rejecting16


title: non-rejecting115


title: non-rejecting201


title: TCMR8


title: ABMR45


title: non-rejecting199


title: non-rejecting15


title: non-rejecting159


title: TCMR9


title: non-rejecting198


title: non-rejecting200


title: TCMR7


title: non-rejecting160


title: non-rejecting161


title: non-rejecting197


title: non-rejecting75


title: non-rejecting255


title: ABMR47


title: ABMR46


title: ABMR44


title: non-rejecting52


title: non-rejecting254


title: non-rejecting51


title: non-rejecting72


title: non-rejecting195


title: non-rejecting196


title: ABMR43


title: non-rejecting194


title: non-rejecting14


title: non-rejecting73


title: non-rejecting261


title: non-rejecting13


title: non-rejecting74


title: ABMR41


title: non-rejecting158


title: non-rejecting12


title: non-rejecting274


title: non-rejecting71


title: MIXED10


title: Nephrectomy5


title: Nephrectomy3


title: non-rejecting68


title: ABMR42


title: non-rejecting114


title: non-rejecting113


title: Nephrectomy4


title: non-rejecting156


title: non-rejecting70


title: TCMR6


title: ABMR35


title: TCMR5


title: ABMR39


title: non-rejecting191


title: ABMR38


title: non-rejecting157


title: MIXED9


title: non-rejecting193


title: ABMR40


title: non-rejecting11


title: non-rejecting192


title: non-rejecting273


title: ABMR34


title: non-rejecting190


title: TCMR4


title: ABMR37


title: non-rejecting9


title: ABMR36


title: ABMR33


title: non-rejecting69


title: non-rejecting189


title: ABMR4


title: non-rejecting154


title: non-rejecting112


title: non-rejecting253


title: MIXED5


title: non-rejecting67


title: ABMR30


title: non-rejecting109


title: ABMR32


title: non-rejecting10


title: non-rejecting188


title: non-rejecting107


title: non-rejecting272


title: MIXED7


title: non-rejecting155


title: non-rejecting7


title: non-rejecting111


title: MIXED8


title: non-rejecting153


title: ABMR3


title: ABMR29


title: MIXED6


title: non-rejecting108


title: MIXED4


title: non-rejecting187


title: non-rejecting66


title: non-rejecting106


title: ABMR28


title: MIXED3


title: ABMR27


title: ABMR2


title: ABMR31


title: non-rejecting151


title: non-rejecting110


title: Nephrectomy2


title: non-rejecting150


title: TCMR2


title: non-rejecting149


title: Nephrectomy1


title: non-rejecting65


title: ABMR26


title: non-rejecting8


title: non-rejecting6


title: ABMR25


title: TCMR3


title: ABMR1


title: non-rejecting186


title: non-rejecting152


title: ABMR24


title: non-rejecting64


title: non-rejecting184


title: MIXED2


title: ABMR22


title: ABMR21


title: non-rejecting148


title: MIXED1


title: non-rejecting2


title: ABMR19


title: non-rejecting5


title: TCMR1


title: non-rejecting185


title: non-rejecting1


title: non-rejecting4


title: ABMR23


title: ABMR20


title: non-rejecting3


title: non-rejecting105


title: ABMR18


title: non-rejecting146


title: non-rejecting183


title: non-rejecting181


title: Br Ca Pt sample #E4534878-1

status: Public on Jan 01 2013

city: Princeton

first: Christine

last: Horak

state: NJ

address: Route 206 and Province Line Road

institute: Bristol-Myers Squibb

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87637_H133A2_E4534878_1

hyb_protocol: Labeled cRNA targets with greater than or equal to 10 micrograms yield were hybridized Affymetrix Human Genome (HG) U133A 2.0 GeneChips

scan_protocol: Affymetrix GeneChip Scanner 3000

data_processing: RMA background correction and normalization using R (v.2.8.1) and affy package (v.1.20.2)

label_protocol: Biotinylated cRNA were prepared according to the Affymetrix in vitro transcription (IVT) labeling kit

extract_protocol: Total RNA was extracted from RNAlater samples using standard procedures.

tag: specimen name

tag: gender

value: female

tag: age

tag: treatment arm

value: Paclitaxel

tag: ac response

value: partial response

tag: basetms

tag: er

value: negative

tag: pr

value: other

tag: mnssl

value: post-menopausal

tag: pcr

value: No


title: Br Ca Pt sample #S1121937-4

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80472_H133A2_S1121937_4

value: > 5 cm


title: Br Ca Pt sample #S1172329-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80479_H133A2_S1172329_1

value: Yes


title: Br Ca Pt sample #S1005947-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56180_H133A2_S1005947_1


title: Br Ca Pt sample #S0869902-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_52104_H133A2_S0869902_1

value: pre-menopausal


title: Br Ca Pt sample #E3416698-4

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_81472_H133A2_E3416698_4

value: stable disease


title: Br Ca Pt sample #A7585244-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92068_H133A2_A7585244_1


title: non-rejecting180


title: non-rejecting147


title: Br Ca Pt sample #A7341588-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_95880_H133A2_A7341588_1

value: unable to determine


title: Br Ca Pt sample #S1172323-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80486_H133A2_S1172323_1


title: Br Ca Pt sample #S1172337-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87447_H133A2_S1172337_1


title: non-rejecting63


title: non-rejecting252


title: Br Ca Pt sample #A6999299-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92062_H133A2_A6999299_1


title: Br Ca Pt sample #S1148759-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87462_H133A2_S1148759_1


title: Br Ca Pt sample #E4376533-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_81484_H133A2_E4376533_1


title: Br Ca Pt sample #E3800097-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87666_H133A2_E3800097_1

value: complete response


title: Br Ca Pt sample #A7274132-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87402_H133A2_A7274132_1


title: Br Ca Pt sample #E4534827-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92079_H133A2_E4534827_1


title: Br Ca Pt sample #A7241232-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_95878_H133A2_A7241232_1

value: progressive disease


title: Br Ca Pt sample #E3800095-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87650_H133A2_E3800095_1

value: < 2 cm


title: Br Ca Pt sample #A6999201-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87419_H133A2_A6999201_1


title: Br Ca Pt sample #E3837748-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87658_H133A2_E3837748_1


title: Br Ca Pt sample #S1172335-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87449_H133A2_S1172335_1


title: non-rejecting182

value: non-rejecting

value: Others


title: Br Ca Pt sample #E4785455-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92073_H133A2_E4785455_1

value: female


title: Br Ca Pt sample #A7241234-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87408_H133A2_A7241234_1

value: Paclitaxel


title: Br Ca Pt sample #E3800093-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87623_H133A2_E3800093_1

value: partial response


title: Br Ca Pt sample #E4340698-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87640_H133A2_E4340698_1

value: negative


title: Br Ca Pt sample #A6914218-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83650_H133A2_A6914218_1

value: other


title: Br Ca Pt sample #E4332198-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83724_H133A2_E4332198_1

value: not reported


title: Br Ca Pt sample #S1134710-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83207_H133A2_S1134710_1


title: Br Ca Pt sample #A6765383-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83654_H133A2_A6765383_1

value: post-menopausal


title: Br Ca Pt sample #E3837738-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87631_H133A2_E3837738_1

value: No


title: Br Ca Pt sample #S1083021-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87438_H133A2_S1083021_1

value: > 5 cm


title: Br Ca Pt sample #A7014562-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83641_H133A2_A7014562_1

value: peri-menopausal

value: Yes


title: Br Ca Pt sample #A6779101-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83645_H133A2_A6779101_1

value: stable disease


title: Br Ca Pt sample #A7013452-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83640_H133A2_A7013452_1

value: pre-menopausal


title: Br Ca Pt sample #A6718367-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87415_H133A2_A6718367_1


title: Br Ca Pt sample #E4376535-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_81474_H133A2_E4376535_1

value: complete response


title: Br Ca Pt sample #E3665683-2

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56189_H133A2_E3665683_2

value: unable to determine


title: Br Ca Pt sample #S1121955-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80477_H133A2_S1121955_1


title: Br Ca Pt sample #S1087426-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83210_H133A2_S1087426_1


title: Br Ca Pt sample #E3800107-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56192_H133A2_E3800107_1


title: Br Ca Pt sample #S1123417-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56183_H133A2_S1123417_1


title: Br Ca Pt sample #A6719813-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87412_H133A2_A6719813_1


title: Br Ca Pt sample #A6926678-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56171_H133A2_A6926678_1


title: Br Ca Pt sample #A7181967-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83651_H133A2_A7181967_1


title: Br Ca Pt sample #E3916682-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_81477_H133A2_E3916682_1


title: Br Ca Pt sample #A6719817-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87410_H133A2_A6719817_1


title: Br Ca Pt sample #S1089748-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56184_H133A2_S1089748_1


title: Br Ca Pt sample #E3665687-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56191_H133A2_E3665687_1


title: Br Ca Pt sample #A6432766-4

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56174_H133A2_A6432766_4


title: Br Ca Pt sample #A6432766-3

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53534_H133A2_A6432766_3


title: Br Ca Pt sample #A6432766-2

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56173_H133A2_A6432766_2


title: Br Ca Pt sample #S0952246-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53586_H133A2_S0952246_1


title: Br Ca Pt sample #S0900095-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53584_H133A2_S0900095_1


title: Br Ca Pt sample #S0922641-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53585_H133A2_S0922641_1


title: Br Ca Pt sample #S0895758-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_52108_H133A2_S0895758_1


title: Br Ca Pt sample #S0960943-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53582_H133A2_S0960943_1


title: Br Ca Pt sample #A6263046-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53533_H133A2_A6263046_1


title: Br Ca Pt sample #S0898797-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53577_H133A2_S0898797_1


title: Br Ca Pt sample #E4682893-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87662_H133A2_E4682893_1

value: positive


title: Br Ca Pt sample #E3569371-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_52119_H133A2_E3569371_1


title: Br Ca Pt sample #S0900086-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53589_H133A2_S0900086_1


title: Br Ca Pt sample #S1141081-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83195_H133A2_S1141081_1


title: Br Ca Pt sample #S0922647-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53581_H133A2_S0922647_1


title: Br Ca Pt sample #S0898016-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_52110_H133A2_S0898016_1


title: Br Ca Pt sample #E3569364-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53572_H133A2_E3569364_1


title: Br Ca Pt sample #E3730745-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_52123_H133A2_E3730745_1


title: Br Ca Pt sample #E4690597-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87654_H133A2_E4690597_1


title: Br Ca Pt sample #E4669582-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92090_H133A2_E4669582_1


title: Br Ca Pt sample #L0506126-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92056_H133A2_L0506126_1


title: Br Ca Pt sample #A6779099-4

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56170_H133A2_A6779099_4


title: Br Ca Pt sample #E4830786-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92082_H133A2_E4830786_1


title: Br Ca Pt sample #E3385594-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_52112_H133A2_E3385594_1


title: Br Ca Pt sample #E4751084-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92097_H133A2_E4751084_1


title: Br Ca Pt sample #E3569369-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_52120_H133A2_E3569369_1


title: Br Ca Pt sample #L0661244-4

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92061_H133A2_L0661244_4


title: Br Ca Pt sample #E4669578-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92081_H133A2_E4669578_1


title: Br Ca Pt sample #A7082104-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87423_H133A2_A7082104_1


title: Br Ca Pt sample #E4708765-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87664_H133A2_E4708765_1


title: Br Ca Pt sample #E3837746-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87669_H133A2_E3837746_1


title: Br Ca Pt sample #L0638234-4

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87399_H133A2_L0638234_4


title: Br Ca Pt sample #S1121939-4

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87457_H133A2_S1121939_4


title: Br Ca Pt sample #S1230610-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87466_H133A2_S1230610_1


title: Br Ca Pt sample #E4343519-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87655_H133A2_E4343519_1


title: Br Ca Pt sample #E3837736-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87629_H133A2_E3837736_1


title: Br Ca Pt sample #E4477304-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87617_H133A2_E4477304_1


title: Br Ca Pt sample #E4597705-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87613_H133A2_E4597705_1


title: Br Ca Pt sample #E4597715-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87635_H133A2_E4597715_1


title: Br Ca Pt sample #S1076358-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87445_H133A2_S1076358_1


title: Br Ca Pt sample #S1089752-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80464_H133A2_S1089752_1


title: Br Ca Pt sample #S1189557-4

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92104_H133A2_S1189557_4


title: Br Ca Pt sample #E3837744-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87632_H133A2_E3837744_1


title: Br Ca Pt sample #S1032223-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83203_H133A2_S1032223_1


title: Br Ca Pt sample #A6926682-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83643_H133A2_A6926682_1


title: Br Ca Pt sample #E4534882-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87665_H133A2_E4534882_1


title: Br Ca Pt sample #E4830790-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92080_H133A2_E4830790_1


title: Br Ca Pt sample #S0869900-2

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_52103_H133A2_S0869900_2


title: Br Ca Pt sample #S1126094-4

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87452_H133A2_S1126094_4


title: Br Ca Pt sample #E4597711-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87648_H133A2_E4597711_1


title: Br Ca Pt sample #E3837750-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87657_H133A2_E3837750_1


title: Br Ca Pt sample #E4751064-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92086_H133A2_E4751064_1


title: Br Ca Pt sample #E4477302-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87619_H133A2_E4477302_1


title: Br Ca Pt sample #A6997529-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92069_H133A2_A6997529_1


title: Br Ca Pt sample #E4597721-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92092_H133A2_E4597721_1


title: Br Ca Pt sample #S1184746-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83198_H133A2_S1184746_1


title: Br Ca Pt sample #L0506122-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87397_H133A2_L0506122_1


title: Br Ca Pt sample #E4597717-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87649_H133A2_E4597717_1


title: Br Ca Pt sample #E4242180-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_81475_H133A2_E4242180_1


title: Br Ca Pt sample #S1178760-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87440_H133A2_S1178760_1


title: Br Ca Pt sample #S1230608-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87439_H133A2_S1230608_1


title: Br Ca Pt sample #S1189561-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83204_H133A2_S1189561_1


title: Br Ca Pt sample #S1148753-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83200_H133A2_S1148753_1

value: < 2 cm


title: Br Ca Pt sample #E4343391-3

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_81479_H133A2_E4343391_3

value: female


title: Br Ca Pt sample #E4343391-4

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_81478_H133A2_E4343391_4

value: Paclitaxel


title: Br Ca Pt sample #E4597719-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87641_H133A2_E4597719_1

value: partial response


title: Br Ca Pt sample #S1005927-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80481_H133A2_S1005927_1

value: negative


title: Br Ca Pt sample #S1089750-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80466_H133A2_S1089750_1

value: other


title: Br Ca Pt sample #E4555795-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92072_H133A2_E4555795_1


title: Br Ca Pt sample #S1032219-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87456_H133A2_S1032219_1


title: Br Ca Pt sample #A7013465-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83639_H133A2_A7013465_1


title: Br Ca Pt sample #A7241230-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83649_H133A2_A7241230_1


title: Br Ca Pt sample #E3665685-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53576_H133A2_E3665685_1

value: Ixabepilone


title: Br Ca Pt sample #S0953605-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53579_H133A2_S0953605_1


title: Br Ca Pt sample #E4606442-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83721_H133A2_E4606442_1


title: Br Ca Pt sample #S1178754-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87446_H133A2_S1178754_1


title: Br Ca Pt sample #A7347583-3

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83657_H133A2_A7347583_3


title: Br Ca Pt sample #S0922645-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53583_H133A2_S0922645_1

value: post-menopausal


title: Br Ca Pt sample #E4532900-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92077_H133A2_E4532900_1

value: No


title: Br Ca Pt sample #E4343391-2

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_81480_H133A2_E4343391_2


title: Br Ca Pt sample #S1148763-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80483_H133A2_S1148763_1


title: Br Ca Pt sample #S1230600-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87454_H133A2_S1230600_1


title: Br Ca Pt sample #A6719815-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87414_H133A2_A6719815_1

value: > 5 cm


title: Br Ca Pt sample #S1091332-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80482_H133A2_S1091332_1


title: Br Ca Pt sample #E4343515-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92085_H133A2_E4343515_1


title: Br Ca Pt sample #E4343539-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87652_H133A2_E4343539_1


title: Br Ca Pt sample #A6952002-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83647_H133A2_A6952002_1


title: Br Ca Pt sample #E4639355-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87642_H133A2_E4639355_1


title: Br Ca Pt sample #E3569373-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_52121_H133A2_E3569373_1


title: Br Ca Pt sample #S0953607-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53578_H133A2_S0953607_1


title: Br Ca Pt sample #S0869886-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56186_H133A2_S0869886_1


title: Br Ca Pt sample #A7013456-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87403_H133A2_A7013456_1


title: Br Ca Pt sample #S0898799-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53591_H133A2_S0898799_1


title: Br Ca Pt sample #S1172331-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80478_H133A2_S1172331_1


title: Br Ca Pt sample #A7585250-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92065_H133A2_A7585250_1


title: Br Ca Pt sample #L0638222-4

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92057_H133A2_L0638222_4


title: Br Ca Pt sample #S1005937-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56178_H133A2_S1005937_1

value: peri-menopausal


title: Br Ca Pt sample #S1172333-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87463_H133A2_S1172333_1


title: Br Ca Pt sample #S1121941-4

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87450_H133A2_S1121941_4


title: Br Ca Pt sample #E4751082-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92076_H133A2_E4751082_1


title: Br Ca Pt sample #A7082075-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87421_H133A2_A7082075_1


title: Br Ca Pt sample #E3837740-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87656_H133A2_E3837740_1

value: Yes


title: Br Ca Pt sample #S1005933-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56181_H133A2_S1005933_1

value: stable disease


title: Br Ca Pt sample #E3800099-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87661_H133A2_E3800099_1

value: pre-menopausal


title: Br Ca Pt sample #A7181973-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_95879_H133A2_A7181973_1

value: not reported


title: Br Ca Pt sample #E3385596-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87643_H133A2_E3385596_1


title: Br Ca Pt sample #E4791654-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92099_H133A2_E4791654_1


title: Br Ca Pt sample #A6997527-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92066_H133A2_A6997527_1


title: Br Ca Pt sample #S1037482-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56185_H133A2_S1037482_1


title: Br Ca Pt sample #L0638218-4

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92058_H133A2_L0638218_4


title: Br Ca Pt sample #S1038591-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87459_H133A2_S1038591_1


title: Br Ca Pt sample #E3416702-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87624_H133A2_E3416702_1


title: Br Ca Pt sample #A7342589-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87409_H133A2_A7342589_1


title: Br Ca Pt sample #E4555791-2

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87621_H133A2_E4555791_2


title: Br Ca Pt sample #A7347583-2

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83656_H133A2_A7347583_2


title: Br Ca Pt sample #E4555791-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87620_H133A2_E4555791_1


title: Br Ca Pt sample #E4555791-3

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87622_H133A2_E4555791_3


title: Br Ca Pt sample #L0638232-4

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92059_H133A2_L0638232_4

value: complete response


title: Br Ca Pt sample #A7181969-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83646_H133A2_A7181969_1


title: Br Ca Pt sample #S1230596-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83201_H133A2_S1230596_1


title: Br Ca Pt sample #E4343543-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87611_H133A2_E4343543_1

value: unable to determine


title: Br Ca Pt sample #E3416700-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87614_H133A2_E3416700_1


title: Br Ca Pt sample #E4597723-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87612_H133A2_E4597723_1


title: Br Ca Pt sample #E3648194-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87625_H133A2_E3648194_1


title: Br Ca Pt sample #A6914216-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83648_H133A2_A6914216_1


title: Br Ca Pt sample #S1212000-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83202_H133A2_S1212000_1


title: Br Ca Pt sample #A7347583-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83655_H133A2_A7347583_1


title: Br Ca Pt sample #S1121963-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80485_H133A2_S1121963_1


title: Br Ca Pt sample #S1172325-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83194_H133A2_S1172325_1


title: Br Ca Pt sample #S1038593-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80480_H133A2_S1038593_1


title: Br Ca Pt sample #E4376531-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_81482_H133A2_E4376531_1


title: Br Ca Pt sample #E4242182-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_81476_H133A2_E4242182_1


title: Br Ca Pt sample #E4332194-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83722_H133A2_E4332194_1


title: Br Ca Pt sample #S1123415-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_81814_H133A2_S1123415_1


title: Br Ca Pt sample #S1005949-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56177_H133A2_S1005949_1


title: Br Ca Pt sample #S1121959-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80476_H133A2_S1121959_1


title: Br Ca Pt sample #A6718068-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87413_H133A2_A6718068_1


title: Br Ca Pt sample #S1005935-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_81809_H133A2_S1005935_1


title: Br Ca Pt sample #A6719819-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87411_H133A2_A6719819_1


title: Br Ca Pt sample #E3569362-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53575_H133A2_E3569362_1


title: Br Ca Pt sample #S1183157-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80463_H133A2_S1183157_1


title: Br Ca Pt sample #S1121945-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80475_H133A2_S1121945_1


title: Br Ca Pt sample #E3663949-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53574_H133A2_E3663949_1


title: Br Ca Pt sample #S0898012-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_52111_H133A2_S0898012_1


title: Br Ca Pt sample #A6926680-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56172_H133A2_A6926680_1


title: Br Ca Pt sample #S1089744-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_56176_H133A2_S1089744_1


title: Br Ca Pt sample #S0895756-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53580_H133A2_S0895756_1


title: Br Ca Pt sample #S0895765-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_52100_H133A2_S0895765_1


title: Br Ca Pt sample #E3569360-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_52122_H133A2_E3569360_1


title: Br Ca Pt sample #S0960945-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_53587_H133A2_S0960945_1


title: Br Ca Pt sample #S0895769-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_52102_H133A2_S0895769_1


title: Br Ca Pt sample #E3730747-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_52114_H133A2_E3730747_1


title: Br Ca Pt sample #E3385598-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_52113_H133A2_E3385598_1


title: Br Ca Pt sample #E4830792-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92083_H133A2_E4830792_1

value: positive


title: Br Ca Pt sample #E4343389-2

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87628_H133A2_E4343389_2

value: female


title: Br Ca Pt sample #E4719356-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92084_H133A2_E4719356_1


title: Br Ca Pt sample #E4751058-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87659_H133A2_E4751058_1


title: Br Ca Pt sample #E4597713-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87663_H133A2_E4597713_1


title: Br Ca Pt sample #E4534823-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92071_H133A2_E4534823_1


title: Br Ca Pt sample #E4669580-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92075_H133A2_E4669580_1


title: Br Ca Pt sample #E4999453-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92089_H133A2_E4999453_1


title: Br Ca Pt sample #L0638228-4

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87398_H133A2_L0638228_4


title: Br Ca Pt sample #E4751060-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92078_H133A2_E4751060_1


title: Br Ca Pt sample #E4764497-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87670_H133A2_E4764497_1

value: UNKNOWN


title: Br Ca Pt sample #E4690599-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87616_H133A2_E4690599_1

value: partial response


title: Br Ca Pt sample #E4708767-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92093_H133A2_E4708767_1

value: negative


title: Br Ca Pt sample #E3837732-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87633_H133A2_E3837732_1

value: other


title: Br Ca Pt sample #E4343389-4

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87626_H133A2_E4343389_4

value: Ixabepilone


title: Br Ca Pt sample #E4343389-3

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87627_H133A2_E4343389_3

value: post-menopausal


title: Br Ca Pt sample #S1148757-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87461_H133A2_S1148757_1


title: Br Ca Pt sample #S1123405-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83199_H133A2_S1123405_1

value: No


title: Br Ca Pt sample #S0895767-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_52101_H133A2_S0895767_1

value: progressive disease


title: Br Ca Pt sample #S1148765-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83209_H133A2_S1148765_1


title: Br Ca Pt sample #S1141089-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_81816_H133A2_S1141089_1


title: Br Ca Pt sample #S1189555-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83206_H133A2_S1189555_1

value: > 5 cm


title: Br Ca Pt sample #A6657371-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87406_H133A2_A6657371_1

value: Yes


title: Br Ca Pt sample #S1134718-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87442_H133A2_S1134718_1

value: stable disease


title: Br Ca Pt sample #S1141087-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_81811_H133A2_S1141087_1

value: pre-menopausal


title: Br Ca Pt sample #S1038597-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_83208_H133A2_S1038597_1


title: Br Ca Pt sample #A7330534-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87401_H133A2_A7330534_1


title: Br Ca Pt sample #S1189563-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92105_H133A2_S1189563_1


title: Br Ca Pt sample #S1121949-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80474_H133A2_S1121949_1


title: Br Ca Pt sample #S1178750-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87467_H133A2_S1178750_1


title: Br Ca Pt sample #A6999199-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_87416_H133A2_A6999199_1


title: Br Ca Pt sample #E3648192-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_81470_H133A2_E3648192_1


title: Br Ca Pt sample #L0488310-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_92055_H133A2_L0488310_1

value: peri-menopausal


title: Br Ca Pt sample #S1076360-1

description:
Gene expression data from pre-treatment breast cancer tumor biopsy
EA08029_80465_H133A2_S1076360_1